Search results for: Value-Based Pricing
Filter search results
Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?
17 March 2020
…London: Office of Health Economics. Available at: https://www.ohe.org/publications/who-technical-report-pricing-cancer-medicines-missing-central-role-hta-and-value Danzon, Towse and Mestre-Ferrandiz (2015). Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context” Health Econ. 24: 294–301. See OHE blog at https://www.ohe.org/news/pricing-variations-within-and-across-countries-gauging-efficiency …
Value Based Pricing in Sweden: Lessons for Design?
11 January 2012
In this Seminar Briefing, Ulf Persson recounts Sweden’s experience with its approach to value based pricing (VBP). The model is a flexible approach that gives weight to cost-offsets outside the…
Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?
1 February 2011
This paper examines the potentially positive impact of differential pricing in Europe and the overall negative effects of international reference pricing (IRP) measures. The authors point out that IRP actually…
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine? Where are we 6 Months on?
1 July 2021
…the key addition of the use of early HTA to set value-based prices instead of cost-based prices, so that vaccines that provide more benefit get relatively higher prices. It is…
Should Drug Prices Differ by Indication? The Debate on Indication-based Pricing
11 May 2018
OHE Consulting has produced a report summarising the literature on indication-based pricing and how it has been applied in the U.S. and 5 European countries. OHE Consulting has produced a…
Time to Tackle the Challenges around Combination Therapies for Cancer
29 March 2021
…and Bruce, A., 2021. Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology. OHE Consulting Report, London: Office of Health Economics. Available at: https://www.ohe.org/publications/why-we-need-new-outcomes-bas https://www.ohe.org/publications/why-we-need-new-outcomes-based-value-attribution-framework-combination-regimens…
Do child QALYs = adult QALYs? Five reasons why they might not
4 February 2020
…values used to weight length of life in calculating QALYs – and the question of whether these values mean the same thing for child as for adult health states. There…
Multi-indication Pricing: Pros, Cons and Applicability to the UK
1 October 2015
…medicines are to reflect their value, then multi-indication medicines should have different prices across major indication, reflecting different values. Multi-indication pricing (MIP) involves setting a different price for each major…
OHE Lunchtime Seminar: How Do We Measure the ‘Value’ in Value-based Care?
19 August 2019
…‘How Do We Measure the ‘Value’ in Value-based Care?’. To be held on 17 September 2019 from 12 p.m. to 2 p.m. Value-based care differs from a fee-for-service approach, in…